MetLife, Inc. (MET) — Fair Value Analysis
Base-case fair value (P50): $68.81 · Current price: $97.66 · Verdict: Overvalued
The Verdict on MET
Based on our Monte Carlo simulations, MetLife (MET) currently appears Deeply Overvalued. With the current market price standing at $97.66, our median fair value (P50) estimate suggests a significantly lower figure of $68.81. This substantial discrepancy indicates an -29.5% gap, strongly implying that investors are paying a premium for MET shares relative to their intrinsic valuation. Our simulations, which model thousands of future scenarios for the Financial Services sector, consistently point to this overvaluation, making the current price a high-risk entry point for new capital.
How MET stacks up against Financial Services
MetLife operates within the Financial Services sector, a dynamic and often complex environment. Our analysis indicates that MET's current valuation, at $97.66, is stretched when compared to its simulated intrinsic value of $68.81. While we currently hold an "unrated" quality tier for MET, which means its operational and financial health against its sector peers is not yet fully quantified, the stark -29.5% difference between the market price and our fair value estimate is a critical concern. This suggests that MET's market valuation isn't justified by the underlying financial prospects modeled in our Monte Carlo framework.
What this means for investors
For investors considering MetLife, the current market price of $97.66 presents a challenging proposition given its Deeply Overvalued status. The simulated median fair value of $68.81 highlights the potential for significant downside, with an -29.5% gap indicating substantial correction risk. While MET's quality tier remains unrated, the valuation signals are clear: current investors are holding shares priced well above their simulated intrinsic worth. For a comprehensive understanding of the bear and bull case scenarios, and to track MET's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is MET overvalued or undervalued right now?
Based on our Monte Carlo simulations, MetLife (MET) is Deeply Overvalued, with a median fair value of $68.81 against its current market price of $97.66.
What is the bear case and bull case for MET?
The full Monte Carlo distribution, including our bear (P10) and bull (P90) case targets and the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here.
How does FairCurve calculate MET's fair value?
FairCurve calculates MET's fair value using Monte Carlo simulations, modeling thousands of forward scenarios to determine a probabilistic range of intrinsic values.
How can I track MET's fair value as it changes?
You can add MET to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation when new earnings or significant fundamental data are released.